Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 Days Payable is 19.34 as of Mar. 2026, which is 52% below its 10-year median of 40.69. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,894 Consumer Packaged Goods companies, Sheel Biotech ranks worse than 85.43% on this metric.
The historical rank and industry rank for Sheel Biotech's Days Payable or its related term are showing as below:
NSE:SHEEL'
s Days Payable Range Over the Past 10 Years
Min: 19.34 Med: 40.69 Max: 64.54
Current: 19.34
During the past 5 years, Sheel Biotech's highest Days Payable was 64.54. The lowest was 19.34. And the median was 40.69.
NSE:SHEEL's Days Payable is ranked worse than 85.43% of 1894
companies
in the Consumer Packaged Goods industry
Industry Median: 44.145
vs NSE:SHEEL: 19.34
Sheel Biotech's Days Payable
declined
from Mar. 2024 (40.69) to Mar. 2026 (19.34).
It may suggest that Sheel Biotechaccelerated paying its suppliers.
Sheel Biotech Days Payable Related Terms
Sheel Biotech Days Payable Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech Days Payable Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Days Payable
64.54
56.91
40.69
24.48
19.34
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Days Payable
64.54
56.91
40.69
24.48
19.34
NSE:SHEEL vs ADM, BG, TSN: Days Payable Comparison
For the Farm Products subindustry, Sheel Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Days Payable distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sheel Biotech's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech (NSE:SHEEL) has a Days Payable of 19.34 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sheel Biotech and its competitors. This is 52% below median its historical median of 40.69. Over the past decade, Sheel Biotech's Days Payable has ranged from 19.34 to 64.54. According to the industry distribution chart, Sheel Biotech ranks #1618 out of 1894 companies in the Consumer Packaged Goods industry, placing it in the top 85.4%.
Is Sheel Biotech's Days Payable too high?
Sheel Biotech's current Days Payable of 19.34 is 52% below median its 10-year median of 40.69. Over the past 10 years, this metric has ranged from a low of 19.34 to a high of 64.54. The Consumer Packaged Goods industry median Days Payable is 44.15. Sheel Biotech's value of 19.34 is 56.2% below this industry median. Based on the distribution chart, Sheel Biotech ranks #1618 out of 1894 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Days Payable compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #1618 out of 1894 companies for Days Payable. This places Sheel Biotech in the lower half of its industry. The industry median Days Payable is 44.15. Sheel Biotech's value of 19.34 is 56.2% below this benchmark. Historically, Sheel Biotech's own Days Payable has ranged from 19.34 to 64.54 over the past decade. While the company's 10-year median is 40.69 vs. the industry median of 44.15, Sheel Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,894 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current Days Payable of 19.34 is 56.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current Days Payable is 19.34, which is 52% below median its own 10-year median of 40.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Days Payable of 19.34. The current Days Payable is 19.34, which is 52% below median its 10-year median of 40.69 and 56.2% below the Consumer Packaged Goods industry median of 44.15. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Days Payable is 19.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
